Patents by Inventor Lan Zhang
Lan Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11943285Abstract: Methods and systems for metering computing resources in cloud computing environments are disclosed. A method includes: executing, by a computing device, computing tasks on computing resources; determining, by the computing device, an amount of time and an amount of power used in the executing the computing tasks on the computing resources; determining, by the computing device, a number of standard units consumed by the computing tasks based on the determined amount of time and the determined amount of power; and metering, by the computing device, the computing resources based on the determined number of standard units consumed by the computing tasks.Type: GrantFiled: March 22, 2019Date of Patent: March 26, 2024Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventors: Li Xia, Lan Luo, Jian Dong Yin, Jian Zhang, Li Long Chen
-
Patent number: 11943373Abstract: An identity certificate may be issued to a blockchain node. The issuance may include issuing a first identity certificate to a first terminal and receiving a second identity certificate issuance request that is from the first terminal. A second identity certificate may be issued to the first terminal, and a third identity certificate issuance request is received from the second terminal. A third identity certificate is issued to the second terminal, so that the second terminal forwards the third identity certificate to the third terminal.Type: GrantFiled: June 2, 2021Date of Patent: March 26, 2024Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITEDInventors: Mao Cai Li, Zong You Wang, Kai Ban Zhou, Chang Qing Yang, Hu Lan, Li Kong, Jin Song Zhang, Yi Fang Shi, Geng Liang Zhu, Qu Cheng Liu, Qiu Ping Chen
-
Publication number: 20240097056Abstract: A back passivation crystalline silicon solar cell includes an Ag gate finger electrode, a SiNx passivation antireflection layer, an N+ layer, P-type silicon, a back passivation layer, and an Al gate finger electrode, connected sequentially from top to bottom. The Ag gate finger electrode sequentially penetrates through the SiNx passivation antireflection layer and the N+ layer and is connected to the P-type silicon by means of an N++ layer. The Al gate finger electrode penetrates through the back passivation layer and is connected to the P-type silicon by a P+ layer. The back passivation layer is a passivation antireflection laminated structure that includes a SiO2 passivation layer, an AlOx passivation layer, a SiNx antireflection layer, and a SiOxNy antireflection layer, sequentially provided from top to bottom. The solar cell has high carrier selectivity, high temperature stability, excellent interface passivation effect and PID resistance, high conversion efficiency and high stability.Type: ApplicationFiled: August 13, 2020Publication date: March 21, 2024Applicants: Tongwei Solar (Chengdu) Co., Ltd., Tongwie Solar (Meishan) Co., Ltd.Inventors: Peng ZHANG, Kun CHEN, Lan WANG, Zhiwei YIN
-
Patent number: 11927865Abstract: An electrochromic device with side-by-side structure including a common electrode unit, at least one color-changing unit and an electrolyte layer is provided. The common electrode unit includes an electrode layer and an electrode protection layer disposed on the electrode layer. The color-changing unit includes a transparent conductive layer and a color-changing layer disposed on the transparent conductive layer. The common electrode unit and each color-changing unit are arranged on the same plane with an insulating region between two adjacent units. The electrolyte layer covers and connects the electrode protection layer of the common electrode unit and the color-changing layer of each color-changing unit.Type: GrantFiled: January 7, 2019Date of Patent: March 12, 2024Assignee: WUYI UNIVERSITYInventors: Xiufeng Tang, Guoxin Chen, Yongxian Li, Zhixin Li, Zhaopeng Mo, Zhijun Ou, Tengcheng Huang, Lan Su, Zehui Zhang, Jianyi Luo
-
Patent number: 11911453Abstract: The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The vaccine can be formulated in a lipid nanoparticle.Type: GrantFiled: January 28, 2019Date of Patent: February 27, 2024Assignee: ModernaTX, Inc.Inventors: Giuseppe Ciaramella, Kapil Bahl, Amy Espeseth, Andrew J. Bett, Pedro Cejas, Lan Zhang, Christine Shaw
-
Patent number: 11871772Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.Type: GrantFiled: August 8, 2019Date of Patent: January 16, 2024Assignee: Firmenich IncorporatedInventors: Joseph R. Fotsing, Andrew Patron, Guy Servant, Lan Zhang, Mark Williams, Qing Chen, Kenneth Simone, Vincent Darmohusodo, Chad Priest, Melissa S. Wong, Thomas Brady
-
Patent number: 11842143Abstract: A method, computer system, and a computer program product is provided for generating a detailed thumbnail and/or preview of a content. In one embodiment the technique comprises analyzing data obtained from a content and classifying it according to a plurality of specific types. A plurality of key information may be then extracted from the data according to the classification. A plurality of key-values are correlated to the plurality of key information so as to provide a plurality of key-value pairs. These pairs are consolidated accordingly to generate a thumbnail and/or a preview that at least renders the key information provided by the consolidated key-value pairs as a rendering.Type: GrantFiled: August 30, 2022Date of Patent: December 12, 2023Assignee: International Business Machines CorporationInventors: Dong Rui Li, Zai Ming Lao, Ye Chen, Xue Lan Zhang, Xue Xu
-
Publication number: 20230310576Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.Type: ApplicationFiled: November 14, 2022Publication date: October 5, 2023Applicant: ModernaTX, Inc.Inventors: Giuseppe Ciaramella, Eric Yi-Chun Huang, Kerim Babaoglu, Jessica Anne Flynn, Lan Zhang, David Nickle
-
Patent number: 11752206Abstract: Herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.Type: GrantFiled: March 15, 2018Date of Patent: September 12, 2023Assignee: ModernaTX, Inc.Inventors: Giuseppe Ciaramella, Shinu John, Andrew J. Bett, Danilo R. Casimiro, Dai Wang, Lan Zhang
-
Publication number: 20230225684Abstract: In an embodiment, a method (100) is described. The method comprises receiving (102) data corresponding to a plurality of radiographic imaging slices of a body. The method further comprises determining (104) a position of a needle inserted in the body. The determination is based on combining information from at least one of the radiographic imaging slices comprising an indication of a first portion of the needle outside the body and at least one other of the radiographic imaging slices comprising an indication of a second portion of the needle inside the body. A combined needle region is generated by merging data corresponding to a position of the first portion of the needle outside the body with data corresponding to a position of the second portion of the needle inside the body.Type: ApplicationFiled: June 21, 2021Publication date: July 20, 2023Inventors: YANHUA SHEN, LING FU, YUE MA, DI ZHANG, LAN ZHANG, YUE ZHENG
-
Publication number: 20230212269Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.Type: ApplicationFiled: December 13, 2022Publication date: July 6, 2023Applicant: Merck Sharp & Dohme LLCInventors: Kalpit A. Vora, Kara S. Cox, Aimin Tang, Zhifeng Chen, Daniel DiStefano, Lan Zhang, Hua-Poo Su
-
Publication number: 20230141153Abstract: The disclosure relates to stable RSV F proteins and immunogenic compositions containing the same, as well as methods of using the immunogenic compositions and compositions comprising the RSV F proteins.Type: ApplicationFiled: December 20, 2022Publication date: May 11, 2023Applicant: Merck Sharp & Dohme LLCInventors: Lan Zhang, Arthur Fridman, Eberhard Durr, Andrew Bett
-
Patent number: 11633725Abstract: Here disclosed is a composite catalyst for methane cracking and a method of producing the composite catalyst.Type: GrantFiled: April 30, 2021Date of Patent: April 25, 2023Assignee: Nanyang Technological UniversityInventors: Lan Zhang, Siew Hwa Chan, Bin Miao
-
Patent number: 11576961Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccine. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.Type: GrantFiled: March 15, 2018Date of Patent: February 14, 2023Assignee: ModernaTX, Inc.Inventors: Giuseppe Ciaramella, Eric Yi-Chun Huang, Kerim Babaoglu, Jessica Anne Flynn, Lan Zhang, David Nickle
-
Patent number: 11566065Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.Type: GrantFiled: December 8, 2020Date of Patent: January 31, 2023Assignee: MERCK SHARP & DOHME LLCInventors: Kalpit A. Vora, Kara S. Cox, Aimin Tang, Zhifeng Chen, Daniel DiStefano, Lan Zhang, Hua-Poo Su
-
Patent number: 11566051Abstract: The disclosure relates to stable RSV F proteins and immunogenic compositions containing the same, as well as methods of using the immunogenic compositions and compositions comprising the RSV F proteins.Type: GrantFiled: January 24, 2019Date of Patent: January 31, 2023Assignee: Merck Sharp & Dohme LLCInventors: Lan Zhang, Arthur Fridman, Eberhard Durr, Andrew Bett
-
Patent number: 11537947Abstract: In one example, the present disclosure describes a device, computer-readable medium, and method for automatically learning and facilitating interaction routines involving at least one human participant. In one example, a method includes learning an interaction routine conducted between a human user and a second party, wherein the interaction routine comprises a series of prompts and responses designed to identify and deliver desired information, storing a template of the interaction routine based on the learning, wherein the template includes at least a portion of the series of prompts and responses, detecting, in the course of a new instance of the interaction routine, at least one prompt from the second party that requests a response from the human user, and using the template to provide a response to the prompt so that involvement of the human user in the new instance of the interaction routine is minimized.Type: GrantFiled: April 20, 2020Date of Patent: December 27, 2022Assignee: AT&T Intellectual Property I, L.P.Inventors: Harry Blanchard, Lan Zhang, Gregory Pulz
-
Publication number: 20220378892Abstract: The present invention relates to methods for the recombinant expression of chlamydia major outer membrane protein (MOMP) comprising transforming a population of E. coli host cells with an expression vector comprising a nucleic acid molecule that encodes chlamydia MOMP and encodes a leader sequence for targeting the MOMP to the outer membrane of the cell, wherein the nucleic acid molecule is operatively linked to a promoter. The method of the invention allows expression of MOMP in the outer membrane of the cell, which leads to protein folding that is more like native MOMP relative to a MOMP protein that is expressed intracellularly. Also provided by the invention are uses of the recombinant MOMP in pharmaceutical compositions and methods for the treatment and/or prophylaxis of chlamydia infection and/or the effects thereof.Type: ApplicationFiled: July 1, 2022Publication date: December 1, 2022Applicant: Merck Sharp & Dohme LLCInventors: Lan Zhang, Zhiyun Wen, Craig T. Przysiecki, Puneet Khandelwal, Ping Qiu
-
Publication number: 20220363760Abstract: The present disclosure provides methods of identifying a subject suitable for an immunooncology (I-O) therapy comprising measuring the expression of one or more genes of a pantumor inflammation gene panel. In some aspects, the method further comprises administering an I-O therapy to the subject. In some aspects, the I-O therapy comprises administering an anti-PD-1 antibody or antigen-binding portion thereof or an anti-PD-L1 antibody or antigen-binding portion thereof to the subject.Type: ApplicationFiled: May 29, 2020Publication date: November 17, 2022Applicant: Bristol-Myers Squibb CompanyInventors: Peter M. SZABO, Lan ZHANG, Keyur H. DESAI, Neeraj ADYA, Zhenhao QI, Kim ZERBA, Scott Adams ELY, Saumya PANT, George A. GREEN
-
Publication number: 20220330591Abstract: The present disclosure generally provides compounds that antagonize certain T2R taste receptors, including related uses, methods, and compositions for the reduction of bitter taste and/or the enhancement of sweet taste. In certain aspects, the disclosure provides flavored articles or flavored compositions comprising such compounds, as well as uses of such compounds to reduce the bitter taste and/or enhance the sweet taste of such flavored articles or flavored compositions.Type: ApplicationFiled: August 8, 2019Publication date: October 20, 2022Applicant: Firmenich IncorporatedInventors: Joseph R. Fotsing, Andrew Patron, Guy Servant, Lan Zhang, Mark Williams, Qing Chen, Kenneth Simone, Vincent Darmohusodo, Chad Priest, Melissa S. Wong, Thomas Brady